Miller Richard A Md - Net Worth and Insider Trading

Miller Richard A Md Net Worth

The estimated net worth of Miller Richard A Md is at least $11 Million dollars as of 2024-12-27. Miller Richard A Md is the President and CEO of Corvus Pharmaceuticals Inc and owns about 2,067,753 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $11 Million. Details can be seen in Miller Richard A Md's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Miller Richard A Md has not made any transactions after 2024-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Miller Richard A Md

To

Miller Richard A Md Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Miller Richard A Md owns 2 companies in total, including Corvus Pharmaceuticals Inc (CRVS) , and Bolt Biotherapeutics Inc (BOLT) .

Click here to see the complete history of Miller Richard A Md’s form 4 insider trades.

Insider Ownership Summary of Miller Richard A Md

Ticker Comapny Transaction Date Type of Owner
CRVS Corvus Pharmaceuticals Inc 2024-05-06 director & President and CEO
BOLT Bolt Biotherapeutics Inc 2022-03-24 director

Miller Richard A Md Latest Holdings Summary

Miller Richard A Md currently owns a total of 1 stock. Miller Richard A Md owns 2,067,753 shares of Corvus Pharmaceuticals Inc (CRVS) as of May 6, 2024, with a value of $11 Million.

Latest Holdings of Miller Richard A Md

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRVS Corvus Pharmaceuticals Inc 2024-05-06 2,067,753 5.23 10,814,348

Holding Weightings of Miller Richard A Md


Miller Richard A Md Form 4 Trading Tracker

According to the SEC Form 4 filings, Miller Richard A Md has made a total of 11 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 577,634 shares on May 6, 2024, which cost Miller Richard A Md around $999,307.

Insider Trading History of Miller Richard A Md

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Miller Richard A Md Trading Performance

GuruFocus tracks the stock performance after each of Miller Richard A Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Miller Richard A Md is 6.22%. GuruFocus also compares Miller Richard A Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Miller Richard A Md within 3 months outperforms 11 times out of 22 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Miller Richard A Md's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Miller Richard A Md

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
10 out of 21 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.73 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 18 LIMIT LIMIT LIMIT LIMIT LIMIT

Miller Richard A Md Ownership Network

Ownership Network List of Miller Richard A Md

No Data

Ownership Network Relation of Miller Richard A Md

Insider Network Chart

Miller Richard A Md Owned Company Details

What does Corvus Pharmaceuticals Inc do?

Who are the key executives at Corvus Pharmaceuticals Inc?

Miller Richard A Md is the director & President and CEO of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include See Remarks William Benton Jones , Chief Financial Officer Leiv Lea , and 10 percent owner Ecor1 Capital, Llc .

Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary

Over the past 18 months, Miller Richard A Md made 1 insider transaction in Corvus Pharmaceuticals Inc (CRVS) with a net purchase of 577,634. Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 20,000 shares made by William Benton Jones ,

In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 597,634 shares were bought by its insiders, resulting in a net purchase of 597,634 shares.

Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corvus Pharmaceuticals Inc Insider Transactions

No Available Data

Miller Richard A Md Mailing Address

Above is the net worth, insider trading, and ownership report for Miller Richard A Md. You might contact Miller Richard A Md via mailing address: Pharmacyclics Inc, 995 E Arques Ave, Sunnyvale Ca 94085-4521.

Discussions on Miller Richard A Md

No discussions yet.